146 related articles for article (PubMed ID: 9638059)
1. [Tumor suppressors--genes and proteins].
Lothe RA; Blomhoff HK
Tidsskr Nor Laegeforen; 1998 May; 118(12):1887-92. PubMed ID: 9638059
[TBL] [Abstract][Full Text] [Related]
2. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
Lerman MI; Minna JD
Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
[TBL] [Abstract][Full Text] [Related]
3. [Tumor suppressor genes].
Sedlácek Z; Mares J; Goetz P
Cas Lek Cesk; 1997 Jan; 136(1):11-6. PubMed ID: 9147846
[TBL] [Abstract][Full Text] [Related]
4. Cancer genetics.
Knudson AG
Am J Med Genet; 2002 Jul; 111(1):96-102. PubMed ID: 12124744
[TBL] [Abstract][Full Text] [Related]
5. [Better understanding of the biology of cancer cells].
Klein G
Lakartidningen; 2000 Jul; 97(28-29):3260-4. PubMed ID: 10997012
[TBL] [Abstract][Full Text] [Related]
6. Genetic susceptibility to cancer. ICRP publication 79. Approved by the Commission in May 1997. International Commission on Radiological Protection.
Ann ICRP; 1998; 28(1-2):1-157. PubMed ID: 10406427
[TBL] [Abstract][Full Text] [Related]
7. The cell-type-specificity of inherited predispositions to tumours: review and hypothesis.
Bignold LP
Cancer Lett; 2004 Dec; 216(2):127-46. PubMed ID: 15533589
[TBL] [Abstract][Full Text] [Related]
8. [Better understanding of the biology of cancer cells].
Klein G
Ugeskr Laeger; 2000 Sep; 162(39):5199-204. PubMed ID: 11043045
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathogenesis of pituitary tumors.
Farrell WE; Clayton RN
Front Neuroendocrinol; 2000 Jul; 21(3):174-98. PubMed ID: 10882539
[TBL] [Abstract][Full Text] [Related]
10. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
11. [New tumor suppressor genes in hot spots of human chromosome 3: new methods of identification].
Braga EA; Kashuba VI; Maliukova AV; Loginov VI; Senchenko VN; Bazov IV; Kiselev LL; Zabarovskiĭ ER
Mol Biol (Mosk); 2003; 37(2):194-211. PubMed ID: 12723467
[TBL] [Abstract][Full Text] [Related]
12. [Cancer-protecting genes (tumor-suppressor genes)].
Olsen J
Ugeskr Laeger; 2006 Jun; 168(24):2329-31. PubMed ID: 16822412
[TBL] [Abstract][Full Text] [Related]
13. Mutations and altered expression of the human cancer genes: what they tell us about causes.
Devereux TR; Risinger JI; Barrett JC
IARC Sci Publ; 1999; (146):19-42. PubMed ID: 10353382
[TBL] [Abstract][Full Text] [Related]
14. [Tumor suppressor genes. New perspectives for clinical investigations in cancer].
Paván J; Gualandi F; Rimessi P; Corallini A; Barbanti-Brodano G
Medicina (B Aires); 1994; 54(2):163-8. PubMed ID: 7997135
[TBL] [Abstract][Full Text] [Related]
15. [TP53 mutations and molecular epidemiology].
Otsuka K; Ishioka C
Gan To Kagaku Ryoho; 2007 May; 34(5):683-9. PubMed ID: 17496437
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetics of small cell lung carcinoma.
Wistuba II; Gazdar AF; Minna JD
Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
[TBL] [Abstract][Full Text] [Related]
17. A functional genomics approach for the identification of putative tumor suppressor genes: Dickkopf-1 as suppressor of HeLa cell transformation.
Mikheev AM; Mikheeva SA; Liu B; Cohen P; Zarbl H
Carcinogenesis; 2004 Jan; 25(1):47-59. PubMed ID: 14555616
[TBL] [Abstract][Full Text] [Related]
18. Expression analysis of candidate breast tumour suppressor genes on chromosome 16q.
van Wezel T; Lombaerts M; van Roon EH; Philippo K; Baelde HJ; Szuhai K; Cornelisse CJ; Cleton-Jansen AM
Breast Cancer Res; 2005; 7(6):R998-1004. PubMed ID: 16280054
[TBL] [Abstract][Full Text] [Related]
19. Allelic phasing of a mouse chromosome 11 deficiency influences p53 tumorigenicity.
Biggs PJ; Vogel H; Sage M; Martin LA; Donehower LA; Bradley A
Oncogene; 2003 May; 22(21):3288-96. PubMed ID: 12761499
[TBL] [Abstract][Full Text] [Related]
20. Common fragile sites, extremely large genes, neural development and cancer.
Smith DI; Zhu Y; McAvoy S; Kuhn R
Cancer Lett; 2006 Jan; 232(1):48-57. PubMed ID: 16221525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
